SAM
Sycomore Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.4M | Hold |
23,318
| – | – | 2.24% | 15 |
|
2025
Q1 | $14.4M | Hold |
23,318
| – | – | 2.05% | 16 |
|
2024
Q4 | $14.4M | Buy |
23,318
+7,929
| +52% | +$4.91M | 2.06% | 16 |
|
2024
Q3 | $9.53M | Buy |
15,389
+6,426
| +72% | +$3.98M | 1.58% | 21 |
|
2024
Q2 | $5M | Buy |
8,963
+781
| +10% | +$436K | 0.88% | 34 |
|
2024
Q1 | $4.89M | Buy |
8,182
+1,275
| +18% | +$762K | 1.07% | 29 |
|
2023
Q4 | $3.67M | Sell |
6,907
-2,437
| -26% | -$1.3M | 0.79% | 38 |
|
2023
Q3 | $4.7M | Buy |
9,344
+2,003
| +27% | +$1.01M | 1.2% | 30 |
|
2023
Q2 | $3.75M | Buy |
7,341
+4,275
| +139% | +$2.18M | 0.88% | 35 |
|
2023
Q1 | $1.72M | Sell |
3,066
-1,869
| -38% | -$1.05M | 0.49% | 40 |
|
2022
Q4 | $2.67M | Sell |
4,935
-8,468
| -63% | -$4.58M | 0.74% | 42 |
|
2022
Q3 | $6.89M | Buy |
13,403
+1,852
| +16% | +$952K | 1.95% | 13 |
|
2022
Q2 | $6.19M | Sell |
11,551
-6,806
| -37% | -$3.65M | 1.45% | 15 |
|
2022
Q1 | $10.9M | Buy |
18,357
+400
| +2% | +$237K | 1.9% | 13 |
|
2021
Q4 | $11.9M | Sell |
17,957
-2,810
| -14% | -$1.86M | 1.83% | 14 |
|
2021
Q3 | $12M | Sell |
20,767
-664
| -3% | -$383K | 1.75% | 13 |
|
2021
Q2 | $10.6M | Buy |
21,431
+1,765
| +9% | +$870K | 1.46% | 18 |
|
2021
Q1 | $9.02M | Sell |
19,666
-7,328
| -27% | -$3.36M | 1.75% | 21 |
|
2020
Q4 | $12.6M | Buy |
26,994
+5,661
| +27% | +$2.64M | 2.63% | 11 |
|
2020
Q3 | $9.45M | Buy |
21,333
+2,689
| +14% | +$1.19M | 2.75% | 10 |
|
2020
Q2 | $6.54M | Sell |
18,644
-5,167
| -22% | -$1.81M | 2.92% | 12 |
|
2020
Q1 | $6.75M | Sell |
23,811
-12,724
| -35% | -$3.61M | 3.23% | 9 |
|
2019
Q4 | $11.9M | Buy |
36,535
+4,916
| +16% | +$1.6M | 5.66% | 6 |
|
2019
Q3 | $8.97M | Buy |
31,619
+9,608
| +44% | +$2.73M | 4.76% | 5 |
|
2019
Q2 | $6.42M | Buy |
+22,011
| New | +$6.42M | 3.73% | 10 |
|